Medicare Part D, the outpatient prescription drug benefit for Medicare beneficiaries, provides coverage above a catastrophic threshold for high out-of-pocket drug costs, but there is no cap on total out-of-pocket drug costs that beneficiaries pay each year. Recent legislative proposals would add a cap on out-of-pocket spending under Part D. This analysis focuses on the potential impact of different out-of-pocket spending caps in terms of how many beneficiaries would be affected and how much they could save.
Competing Proposals to Reform Medicare Part D - AAF
/-/media/milliman/images/2023-arti
HHS Selects First 10 Drugs for Medicare Rx Price Negotiation
Explaining the Prescription Drug Provisions in the Build Back
Federal Register :: Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for
Explaining the Prescription Drug Provisions in the Build Back
Options to Make Medicare More Affordable For Beneficiaries Amid the COVID-19 Pandemic and Beyond - Report - 9592
Federal Register :: Medicare Program; Maximum Out-of-Pocket (MOOP) Limits and Service Category Cost Sharing Standards
Key Proposals to Strengthen the Affordable Care Act